BiotechTube

Droperidol

ApprovedTerminated
0 watching 0 views this week🔥 Hot
85
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Nausea

Conditions

Nausea, Vomiting

Trial Timeline

Apr 1, 2007 → Apr 1, 2009

NCT ID
NCT00445055

About Droperidol

Droperidol is a approved stage product being developed by Kyowa Kirin for Nausea. The current trial status is terminated. This product is registered under clinical trial identifier NCT00445055. Target conditions include Nausea, Vomiting.

Hype Score Breakdown

Clinical
30
Activity
20
Company
10
Novelty
10
Community
12

Clinical Trials (1)

NCT IDPhaseStatus
NCT00445055ApprovedTerminated

Competing Products

20 competing products in Nausea

See all competitors
ProductCompanyStageHype Score
Palonosetron 0.075 mg IV + Dexamethasone 10 mg IV + Promethazine 25 mg IVEisaiApproved
85
Sancuso + IV granisetronKyowa KirinPhase 1
33
granisetron transdermal system + Granisetron IVKyowa KirinPhase 1
33
palonesetronEisaiPhase 2
52
Ondansetron + PalonosetronEisaiPhase 2
52
GranisetronKyowa KirinPhase 3
77
Sancuso + IV granisetronKyowa KirinPhase 1
33
LY3537021 + Placebo + Standard of Care Antiemetic Therapies + Background ChemotherapyEli LillyPhase 2
52
esomeprazoleAstraZenecaPhase 3
77
Rolapitant Dose 1 + Rolapitant Dose 2 + Rolapitant Dose 3 + Rolapitant Dose 4 + Ondansetron + PlaceboMerckPhase 2
52
Fosaprepitant dimeglumine + Fosaprepitant Placebo + Dexamethasone + Ondansetron + Dexamethasone Placebo + Ondansetron Placebo + Rescue TherapyMerckPhase 3
77
Aprepitant + Aprepitant Placebo + Ondansetron + Dexamethasone + Ondansetron Placebo + Rescue Therapy (granisetron, dolasetron, tropisetron or ondansetron; metoclopramide or alizapride).MerckApproved
85
Dexamethasone + Aprepitant + Placebo DexamethasoneMerckPre-clinical
23
Comparator: MK0517 + Comparator: ondansetronMerckPhase 3
77
Aprepitant, Dexamethasone, Ondansetron + Aprepitant, Dexamethasone, PlaceboMerckApproved
85
FosaprepitantMerckPhase 2
52
Fosaprepitant + Placebo for fosaprepitant + Ondansetron + Dexamethasone + 5-HT3 antagonistMerckPhase 3
77
Aprepitant + ScopolamineMerckPre-clinical
23
Fosaprepitant + Dexamethasone + 5HT3MerckPhase 2
52
aprepitant + Comparator: Placebo to aprepitant + dexamethasone + granisetron + dexamethasoneMerckPhase 3
77

Other Products from Kyowa Kirin

KRN23Approved
85
Istradefylline PillApproved
85
MogamulizumabApproved
85
KRN23Approved
85
KHK4827-Active + KHK4827-PlaceboApproved
85